Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study

202199 citationsJournal Articlebronze Open Access

Authors

Fabrice Carrat · Inserm

Xavier de Lamballerie · Inserm

Delphine Rahib · Santé Publique France

Hélène Blanché · Fondation Jean Dausset-CEPH

Nathanaël Lapidus · Inserm

Fanny Artaud · Inserm

Sofiane Kab · Inserm

Abstract

Seropositivity to anti-SARS-CoV-2 antibodies in the French adult population was ≤10% after the first wave. Modifiable and non-modifiable risk factors were identified.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Long-Term Effects of COVID-19

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Epidemiology

Volume 50, Issue 5, pp. 1458-1472

DOI: 10.1093/ije/dyab110

Field-Weighted Citation Impact: 5.92